News & Articles
Selected Filters:
Revvity ignites scientific breakthroughs at SLAS2025
Revvity is set to unveil its new Phenologic.AI software at SLAS2025 International Conference & Exhibition in San Diego, California
Revvity broadens relationship with Genomics England to advance genomics in the UK
Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early
The solution for specific typing of Alzheimer's disease
APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s
International consortium to revolutionize viral vector manufacturing
Collaborative project to develop next-generation cell platform for viral vector production receives £1.1 million grant from Innovate UK & NRC
Revvity to provide genome sequencing for Early Check newborn screening study
The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions
Revvity’s EUROIMMUN announces strategic partnership with ALPCO-GeneProof
Partnership aims to expand CE-IVD molecular assay offerings
Revvity unveils a new era of automated tuberculosis testing
The new platform promises to substantially lower hands-on time, allowing for increased lab productivity
Revvity presents cutting-edge solutions at SLAS2024
Showcase will include more than 40 products from its life sciences and diagnostics protfolio